In August 2025, Ningbo, Zhejiang, will host the annual academic event in the field of sex medicine. The "Second East China Sex Medicine Conference" and the concurrent "Sexual Dysfunction Diagnosis and Treatment Technology Training Course" will be held from August 17 to 23. The event is jointly organized by the Chinese Society of Sexual Medicine, Ningbo Yinzhou District Second Hospital, and the male department of Yinzhou Second Hospital. Experts in the field of andrology from across the country are invited to participate in the event to explore the latest technological advances and future directions in the industry.
As the annual academic conference in the andrology field, this event continues the academic influence of the first conference, gathering top experts such as Professor Jiang Hui, President of the Chinese Society of Sexual Medicine, Professor Dai Yutian, and local leaders in the field like Director Xu Zhipeng from Yinzhou Second Hospital, to discuss innovations and clinical practices in andrology diagnosis and treatment.
LIPUS Technology Principles and Clinical Applications
From August 17 to 22, Ningbo Yinzhou District Second Hospital will focus on clinical technology transformation by holding a specialized training course on the diagnosis and treatment of sexual dysfunction. The training will focus on the clinical application of micro-energy medicine, with experts from various fields offering insights on the practical value of LIPUS technology.
Ningbo Yinzhou District Second Hospital's Head Nurse, Qian Chaoxia, will present a lecture titled "Micro-energy Medicine in Andrology" and provide a comprehensive demonstration of the innovative applications of LIPUS technology in areas such as alleviating chronic prostatitis symptoms and improving plaque in penile fibrosclerosis. Her presentation will focus on optimizing treatment plans from a nursing perspective, providing practical references for clinical operations.
At the same time, Lin Fei, Senior Nurse at Ningbo Urology and Kidney Disease Hospital, will deliver a report on "The Principles of LIPUS Technology and Erectile Dysfunction Treatment." The report will detail the core mechanism of low-intensity pulsed ultrasound (LIPUS) technology, which uses specific sound frequencies to stimulate the penile cavernous blood vessels, improving local microcirculation and offering a non-invasive and effective treatment option for erectile dysfunction (ED) patients.
Beyond clinical application analysis, Director Xu Zhipeng from Yinzhou Second Hospital will discuss "Building and Reflecting on Basic Male Medicine" in a report. He will explore the implementation pathways and standardized diagnostic treatment system construction for LIPUS technology in grassroots healthcare settings, offering practical solutions to bring this technology from clinical research to grassroots practice.
Experts Discuss Andrology Diagnosis and Treatment Innovation
On August 23, the Second East China Sex Medicine Conference will continue the academic discussions. Experts such as Professor Jiang Hui, President of the Chinese Society of Sexual Medicine, Professor Dai Yutian, Chair of the Sexual Medicine Subcommittee of the Chinese Society of Sexual Medicine, and Director Xu Zhipeng from Yinzhou Second Hospital will attend and deliver presentations. The focus will be on innovating the entire chain of male health management from prevention and diagnosis to rehabilitation, aiming to establish a standardized treatment system tailored to the physiological characteristics of Chinese men.
Clinical Translation of Micro-energy Medicine
WBL Medical Group will showcase its research and development strength in the field of micro-energy medicine with LIPUS technology as the core. This technology differs from traditional drug treatments, which depend on medications, and from surgical interventions that can be invasive. Through non-invasive physical stimulation, LIPUS activates the body's self-healing ability and has demonstrated good safety and efficacy in clinical trials, providing an innovative solution for diagnosing and treating andrological diseases.
WBL LIPUS Technology Principles and Treatment Effects
The core mechanism of WBL's LIPUS technology involves the use of low-energy pulsed ultrasound (sound intensity range of 50-350 mW/cm²) to target the penile cavernous tissue, activating endogenous stem cells, promoting blood vessel and nerve regeneration, and repairing damaged vascular endothelium and neural matrices. This approach improves erectile function at a pathological level. Compared to traditional oral drugs (such as PDE5 inhibitors), prosthetic implants, or invasive therapies (such as intracavernous injections), WBL LIPUS provides a safe, non-invasive treatment method that does not result in drug dependence, side effects, or surgical complications.
Competitive Advantages of WBL LIPUS
1.Non-invasive and Safe
There is no need for drugs or surgery, avoiding the burden on the liver and kidneys as well as the risk of infection, making it especially suitable for patients with chronic diseases (such as diabetes).
2.Comprehensive Treatment Model
The unique "LIPUS + Psychological Counseling + VR" multidimensional therapy combines physical repair with psychological intervention, increasing patient satisfaction by more than 30%.
3.Clinical Data Support
Based on clinical validation from over 60 global medical institutions, its efficacy and safety have been endorsed by authoritative institutions such as UCSF and Peking University Hospital.
From August 17, let us focus on Ningbo and witness this academic event in the field of andrology, as we work together to explore the latest progress and breakthroughs in andrology diagnosis and treatment。